NO20031211L - Plaster omfattende diclofenac - Google Patents

Plaster omfattende diclofenac

Info

Publication number
NO20031211L
NO20031211L NO20031211A NO20031211A NO20031211L NO 20031211 L NO20031211 L NO 20031211L NO 20031211 A NO20031211 A NO 20031211A NO 20031211 A NO20031211 A NO 20031211A NO 20031211 L NO20031211 L NO 20031211L
Authority
NO
Norway
Prior art keywords
diclofenac
active substance
plastics
patch
layer
Prior art date
Application number
NO20031211A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031211D0 (no
Inventor
Isabelle Francine Liebshutz
Cecile Aillaud
Chantal Lapillonne
Original Assignee
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Lab Sa filed Critical Fournier Lab Sa
Publication of NO20031211L publication Critical patent/NO20031211L/no
Publication of NO20031211D0 publication Critical patent/NO20031211D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20031211A 2000-09-18 2003-03-17 Plaster omfattende diclofenac NO20031211D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00120385 2000-09-18
PCT/EP2001/010746 WO2002022109A2 (fr) 2000-09-18 2001-09-17 Composition topique

Publications (2)

Publication Number Publication Date
NO20031211L true NO20031211L (no) 2003-03-17
NO20031211D0 NO20031211D0 (no) 2003-03-17

Family

ID=8169864

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031211A NO20031211D0 (no) 2000-09-18 2003-03-17 Plaster omfattende diclofenac

Country Status (11)

Country Link
US (1) US20040037872A1 (fr)
EP (1) EP1326590A2 (fr)
JP (1) JP2004508397A (fr)
AU (1) AU2002212252A1 (fr)
CA (1) CA2422829A1 (fr)
CZ (1) CZ2003783A3 (fr)
HU (1) HUP0302431A2 (fr)
NO (1) NO20031211D0 (fr)
PL (1) PL360999A1 (fr)
RU (1) RU2003107010A (fr)
WO (1) WO2002022109A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4865958B2 (ja) 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
JP4629578B2 (ja) * 2003-01-22 2011-02-09 ニチバン株式会社 眼疾患治療用経皮吸収型製剤
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
EP2328531A1 (fr) * 2008-09-26 2011-06-08 Novartis AG Pansement pour le traitement des douleurs articulaires, comportant au moins deux timbres transdermiques
US20110054117A1 (en) * 2009-08-27 2011-03-03 Hall Gregory K Polyolefin Adhesive Compositions and Method of Making Thereof
TWI482645B (zh) * 2010-01-07 2015-05-01 Teikoku Seiyaku Kk 含有待克菲那（ｄｉｃｌｏｆｅｎａｃ）羥乙基吡咯啶之外用油性敷貼劑
CN105878214A (zh) * 2014-08-23 2016-08-24 南京海纳医药科技有限公司 一种含双氯芬酸依泊胺的透皮贴剂及其制备方法
CN112461983B (zh) * 2020-04-24 2023-03-21 山东省药学科学院 一种测定巴马小型猪皮肤生物样品中双氯芬酸钠的方法
CN111821285A (zh) * 2020-06-17 2020-10-27 南京海纳医药科技股份有限公司 一种含双氯芬酸依泊胺的透皮贴剂及其制备方法
US20240342125A1 (en) 2021-09-27 2024-10-17 Hisamitsu Pharmaceutical Co., Inc. Method for inhibiting generation of diclofenac indolinones
WO2023048192A1 (fr) * 2021-09-27 2023-03-30 久光製薬株式会社 Procédé d'inhibition de production d'indolinones de diclofénac

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1116900C (zh) * 1993-05-19 2003-08-06 久光制药株式会社 溶剂及含有该溶剂的外用制剂
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
AU718811B2 (en) * 1996-10-30 2000-04-20 Theratech, Inc. Fatty acid esters of glycolic acid and its salts as permeation enhancers
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
DE19804604A1 (de) * 1998-02-06 1999-08-12 Beiersdorf Ag Vorrichtung zur Freigabe von Stoffen
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers

Also Published As

Publication number Publication date
RU2003107010A (ru) 2004-08-27
PL360999A1 (en) 2004-09-20
WO2002022109A2 (fr) 2002-03-21
WO2002022109A3 (fr) 2002-07-18
HUP0302431A2 (hu) 2003-10-28
CA2422829A1 (fr) 2002-03-21
JP2004508397A (ja) 2004-03-18
AU2002212252A1 (en) 2002-03-26
EP1326590A2 (fr) 2003-07-16
US20040037872A1 (en) 2004-02-26
NO20031211D0 (no) 2003-03-17
CZ2003783A3 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
US5464610A (en) Method for treating onychomycosis
DK0680325T3 (da) Transdermalt terapeutisk system med galanthamin som aktiv bestanddel
NO20031211L (no) Plaster omfattende diclofenac
JP2007538008A5 (fr)
BR9815378A (pt) Sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamÈnio diclofenac e o método de fabricação do mesmo.
BRPI0411986A (pt) forma de dosagem farmacêutica multiparticulada, contendo substáncias peptìdicas ou protéicas ativas formuladas de maneira mucoadesiva, e um método para produzir a dita forma de dosagem farmacêutica
DK0439180T3 (da) Transdermalt terapeutisk system med tulubuterol som virksomt stof
NO20074811L (no) Utvendig plaster inneholdende flurbiprofen
BRPI0417437A (pt) dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose
WO2003015779A3 (fr) Systeme therapeutique transdermique a regulation matricielle permettant l'administration de pramipexol et de ropinirol
WO2011029948A3 (fr) Système thérapeutique transdermique pour l'administration de fentanyle ou d'un analogue du fentanyle
CA2387143A1 (fr) Systeme therapeutique transdermique a base d'hydrochlorure de tulobuterol utilise pour administrer le bronchodilatateur tulobuterol par l'intermediaire de la peau
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
ATE354357T1 (de) Transdermales therapeutisches system enthaltend leich flüchtige wirkstoffe
KR100294084B1 (ko) 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
WO2001026637A3 (fr) Systeme therapeutique transdermique permettant de delivrer de l'acide acetylsalicylique et/ou de l'acide salicylique
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
TW200719902A (en) Solid transdermal therapeutic system with uv absorber
BR0212506A (pt) Administração transdérmica de um éster de enalapril
AU2002215988A1 (en) Skin friendly active ingredient plaster for transdermal administration of rubefacient active ingredients
ATE185067T1 (de) Estradiol-tts mit wasserbindenden zusätzen
BR0312333A (pt) Terapia de combinação e agente para sua execução
BR9912688A (pt) Emplastro contendo estradiol para aplicaçãotransdérmica de hormÈnios